These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 553813

  • 21. Effects of rociverine on the human ureter: in vivo and in vitro experimental study.
    Potenzoni D, Zappia L, Sacchini P, Bezzi E.
    Pharmacol Res Commun; 1984 Aug; 16(8):765-74. PubMed ID: 6494219
    [Abstract] [Full Text] [Related]

  • 22. [Colic and spastic states of the urinary tract. Comparison between syntropium bromide (VAL 480) with ioscine n-butylbromide and with noramidopyrine-pitofenone-fenpiverinium bromide].
    Colpi GM, Politi P, Sandri S, Fanciullacci F, Biraghi M, Zanollo A.
    Minerva Urol Nefrol; 1985 Aug; 37(3):341-8. PubMed ID: 3911456
    [No Abstract] [Full Text] [Related]

  • 23. Antispasmodic activity of rociverine on the smooth musculature of the urinary tract. Comparative in vitro study.
    Schiantarelli P, Murmann W.
    Arzneimittelforschung; 1980 Aug; 30(7):1102-9. PubMed ID: 7191292
    [No Abstract] [Full Text] [Related]

  • 24. Rociverine compared with other spasmolytics for cardiovascular effects.
    Guelfi M, Schiantarelli P, Subissi A.
    Farmaco Prat; 1981 Aug; 36(8):374-82. PubMed ID: 7274417
    [No Abstract] [Full Text] [Related]

  • 25. Rociverine citrate: a new spasmolytic agent, potentially useful in the treatment of urinary bladder hyperreflexia.
    Subissi A, Maggi CA, Meli A.
    Jpn J Pharmacol; 1986 Oct; 42(2):153-7. PubMed ID: 3540391
    [Abstract] [Full Text] [Related]

  • 26. [Clinical evaluation of a new spasmolytic: sintropium bromide (VAL 480) in spastic states of the upper and lower urinary tract].
    Colosi V, Arcidiacono G, Mignosa E, Biraghi M.
    Minerva Urol Nefrol; 1986 Oct; 38(3):271-8. PubMed ID: 3810389
    [No Abstract] [Full Text] [Related]

  • 27. Effects of rociverine and other spasmolytic agents on caerulein-induced delay in gastric emptying in the conscious rat.
    Subissi A, Guelfi M.
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):130-7. PubMed ID: 7114969
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [1-ethoxysilatrane--an inhibitor of the development of experimental atherosclerotic lesion of the aorta].
    Konova NS, Pertsovskiĭ AI, Voronkov MG.
    Dokl Akad Nauk SSSR; 1984 May; 276(3):757-9. PubMed ID: 6468268
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Echotomographic, colonoscopic and clinical evaluation of syntropium bromide].
    Vinciguerra V, Doronzo F, Tardi S, Vasti MT, Cecere O, Baldassarre G, Palasciano G, Biraghi M.
    Minerva Dietol Gastroenterol; 1986 May; 32(2):197-201. PubMed ID: 3526191
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Effect of bornaprine in localized hyperhidrosis].
    Castells Rodellas A, Moragón Gordon M, Ramírez Bosca A.
    Med Cutan Ibero Lat Am; 1987 May; 15(4):303-5. PubMed ID: 3320624
    [Abstract] [Full Text] [Related]

  • 40. [Correlation between the stress-protective and vegetotropic action of mebikar].
    Val'dman AV, Zaikonnikova IV, Kozlovskaia MM, Zimakova IE, Bravkov MF.
    Farmakol Toksikol; 1981 May; 44(1):47-9. PubMed ID: 7196343
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.